Fundraising FoxHighCape Capital — Full Portfolio
14 tracked investments · listed companies and verified rows first
Aziyo Biologics (operating as Elutia) develops drug-eluting biomatrix products that combine biologic scaffolds with localized antibiotic delivery to reduce surgical complications in reconstructive and soft tissue repair procedures.
BiotechSilver Spring, US
Michelle LeRoux Williams(Executive Officer)Jeffrey D Hamet(Executive Officer)Lode Debrabandere(Executive Officer, Director)C. Randal Mills(President, Chief Executive Officer, Director)
BoardWilliam Matthew Zuga(Director)Kevin Rakin(Director)in
Offers soft tissue repair solutions combining naturally sourced tissue with polymer; lead product OviTex for hernia repair (NASDAQ: TELA), based in Malvern, PA.
BiotechMalvern, US
Antony Koblish(Founder)inFrancis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)
BoardKevin Rakin(Director)inAshley Freidman(Director)
Co-investorsCheckmate Capital Group LLCEssex Woodlands Healthcare PartnersOrbiMedSignet Healthcare Partners1315 CapitalRTW Investments L.P.
Develops therapeutics targeting altered NAD metabolism in cancer, using IP licensed from Yale University.
BiotechNew Haven, US
Barbara Fox(Executive Officer, Director)inNicholas J Galli(Executive Officer, Director)Stanley Choy(Executive Officer)inRanjit Bindra(Director)in
BoardColleen Cuffaro(Director)inMatthew Cohen(Director)in
Co-investorsCanaan PartnersConnecticut InnovationsOUP (Osage University Partners)
Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.
HealthtechNewton, US
Christopher Hutchison(Executive Officer, Director)inKevin McArdle(Executive Officer)Yuval Rozen(Executive Officer)
BoardSteven Reeders(Director)Renard Charity(Director)inAnthony Moshal(Director)
Co-investorsAscension VenturesBosch VenturesMVM Life Science Partners
Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery.
BiotechHealthtechMedical DevicesNew Haven, US
Per Hellsund(Co-founder, President & CEO)inRanjit Bindra(Scientific Co-founder & Chief Scientific Advisor)inPeter Glazer(Scientific Co-founder & Chief Medical Advisor)inF. Kevin Didden(Manager)
BoardKevin Rakin(Manager)
Co-investorsConnecticut Innovations
Elutia develops a proprietary drug-eluting biomaterial platform that combines biologic matrices with extended antibiotic release for use in device implantation and soft tissue reconstruction.
BiotechHealthtechMedical Devices
C. Randal Mills(Founder, President & CEO)in
MODIFI provides a digital platform for cross-border trade finance, letting exporters and importers onboard online, receive payment right after shipping, and track trades and supplier payouts in one dashboard.
FintechLogistics & Supply ChainSaaSBainbridge Island, US
Jan Wehrs(Founder)inSven Brauer(Founder)inNelson Holzner(Co-Founder & CEO)inJames Poss(Executive Officer, Director, Promoter)Matthew Otepka(Executive Officer)J. Todd Larson(Executive Officer)
Co-investorsFelix JahnIncubate FundMaersk GrowthNeva Sgr.PICUS CAPITALGlobal Founders Capital+1 more
Modifi Bio presents itself as a research-focused biopharmaceutical company developing medicines and vaccines.
BiotechHealthtechNew Haven, US
Ranjit Bindra(Director)inKingson Lin(Cofounder)inKevin L. Rakin(Executive Officer, Director)in
BoardLucas de Breed(Director)Kat Kayser-Bricker(Director)
Co-investorsConnecticut InnovationsPathway BioventuresAdvantage Capital PartnersBrightEdgeIronwood Capital
Quantum-Si develops next-generation protein sequencing technology that enables single amino acid detection by combining biology, chemistry, artificial intelligence, and semiconductor technology.
BiotechDeep TechHardwareMedical Devices
Jeff Hawkins(CEO)inJeff Keyes(Chief Financial Officer)inChristian LaPointe(General Counsel)inTodd Rearick(Chief Technology Officer)inLindsay Thompson(Chief Human Resources Officer)in
Co-investorsForesite CapitalYuanBio Venture Capital
Wellinks provides virtual pulmonary care for patients with respiratory conditions such as COPD, offering at-home remote monitoring, virtual pulmonary rehabilitation, one-on-one clinical coaching, and nurse triage.
Digital HealthHealthtechWellness & FitnessNew Haven, US
Ellen Su(Executive Officer, Director)inLevi DeLuke(Executive Officer, Director)in
Co-investorsConnecticut Innovations
Innovator in non-invasive surgical skin closure devices used in over 100,000 cases across 30+ countries; headquartered in Campbell, CA.
Campbell, US
Amir Belson(Director)John Tighe(Executive Officer, Director)in
BoardPatrick Berbon(Director)Stephen Reeders(Director)Balaji Muralidhar(Director)
Co-investorsClaremont Creek VenturesMVM Life Science PartnersXSeed Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlphinaConvexity ScientificCybrexa Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.